this week played down concerns among some investors that demand for weight-loss drugs may lead to a sharp drop in beer drinking.for new treatments such as Novo Nordisk’s Wegovy has prompted questions about the implications for a range of industries, including brewers, and sparked share
“Two years down the road and that conversation is gone,” he said in an interview after AB InBev’s results on Tuesday, adding that forecasts showed beer drinking would rise. “It’s early days and we can be proven wrong, but we are relaxed about it,” he told Reuters after a trading update.
The WHO says alcohol consumption is a causal factor in more than 200 diseases, injuries and other health conditions. Some clinical trials on rodents have found treatment with GLP-1 agonists reduces alcohol consumption, eases symptoms of alcohol withdrawal and more. headtopics.com
Nevertheless, some investors are worried about the potential impact on brewers if such drugs reduce overall consumption.
Ozempic, Wegovy demand drives up illegal sales of weight-loss drugsToday’s Video Headlines: 11/1/23 Read more ⮕
Exclusive: Novo hires FUJIFILM unit to help make Wegovy weight-loss drugNovo Nordisk (NOVOb.CO) has hired FUJIFILM Diosynth Biotechnologies to fill Wegovy injection pens, a source familiar with the matter told Reuters, as the Danish drugmaker scrambles to boost output of its hugely popular weight-loss drug. Read more ⮕
Why Would Workers Return to a Former Employer?Psychological reasons why people return to previous employers (and why they leave in the first place). Read more ⮕
Why Netflix Cancels So Many Animated TV Shows (& Why It’s A Problem)Netflix cancels a lot of its animated shows, which is not just frustrating for fans but also indicates a problem trend with the streaming platform. Read more ⮕
Anheuser-Busch InBev S.A. ADR falls Wednesday, underperforms marketSupported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with unparalleled accuracy. Read more ⮕
Anheuser-Busch InBev S.A. ADR outperforms market on strong trading daySupported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with unparalleled accuracy. Read more ⮕
